Perioperative treatment in resectable gastric cancer with spartalizumab in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): a phase II study (GASPAR)

被引：0
作者：
Mélanie Dos Santos
Justine Lequesne
Alexandra Leconte
Stéphane Corbinais
Aurélie Parzy
Jean-Marc Guilloit
Sharmini Varatharajah
Pierre-Emmanuel Brachet
Marine Dorbeau
Dominique Vaur
Louis-Bastien Weiswald
Laurent Poulain
Corentin Le Gallic
Marie Castera-Tellier
Marie-Pierre Galais
Bénédicte Clarisse
机构：
[1] UNICANCER,Clinical Research Department
[2] Centre François Baclesse,Department of Medical Oncology
[3] UNICANCER,Department of Surgery
[4] Centre François Baclesse,Department of Pathology
[5] UNICANCERCentre François Baclesse,Department of Cancer Biology and Genetics
[6] UNICANCERCentre François Baclesse,undefined
[7] UNICANCERCentre François Baclesse,undefined
[8] UNICANCER,undefined
[9] Centre François Baclesse,undefined
[10] Normandie University,undefined
[11] UNICAEN,undefined
[12] ANTICIPE,undefined
[13] ORGAPRED Platform,undefined
来源：
BMC Cancer | / 22卷
关键词：
Gastric cancer; Gastroesophageal junction cancer; Neoadjuvant treatment; Immunotherapy; Spartalizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] High FAK combined with low JWA expression: clinical prognostic and predictive role for adjuvant fluorouracil–leucovorin–oxaliplatin treatment in resectable gastric cancer patients
    Yansu Chen
    Xiaowei Xia
    Shouyu Wang
    Xuming Wu
    Jianbing Zhang
    Yan Zhou
    Yongfei Tan
    Song He
    Fulin Qiang
    Aiping Li
    Oluf Dimitri Røe
    Jianwei Zhou
    Journal of Gastroenterology, 2013, 48 : 1034 - 1044
  • [32] Docetaxel, oxaliplatin, leucovorin, and 5-fluorouracil (FLOT) as preoperative and postoperative chemotherapy compared with surgery followed by chemotherapy for patients with locally advanced gastric cancer: a propensity score-based analysis
    Wang, Keshen
    Ren, Yanxian
    Ma, Zhijian
    Li, Fan
    Cheng, Xiaocheng
    Xiao, Jingying
    Zhang, Shuze
    Yu, Zeyuan
    Yang, Hanteng
    Zhou, Huinian
    Li, Yuming
    Liu, Hongbin
    Jiao, Zuo-Yi
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 3009 - 3020
  • [33] ETOPOSIDE, LEUCOVORIN AND 5-FLUOROURACIL IN ADVANCED GASTRIC-CANCER - A PHASE-II STUDY
    VANCUTSEM, E
    FILEZ, L
    DEWYSPELAERE, J
    PENNINCKX, F
    JANSSENS, J
    ANTICANCER RESEARCH, 1995, 15 (03) : 1079 - 1080
  • [34] Etoposide, l-leucovorin and fluorouracil (ELF) regimen in metastatic gastric cancer:: A phase II study
    Adamo, V
    Scimone, A
    Maisano, R
    Altavilla, G
    Ferraro, G
    Laudani, A
    Pergolizzi, S
    Zanghi, M
    JOURNAL OF CHEMOTHERAPY, 1999, 11 (01) : 74 - 77
  • [35] Randomized phase II study of sequential docetaxel and irinotecan with 5-fluorouracil/folinic acid (leucovorin) in patients with advanced gastric cancer: the GATAC trial
    Michael Gubanski
    Anders Johnsson
    Eva Fernebro
    Lianna Kadar
    Ingegerd Karlberg
    Petra Flygare
    Åke Berglund
    Bengt Glimelius
    Pehr A. Lind
    Gastric Cancer, 2010, 13 : 155 - 161
  • [36] Randomized phase II study comparing neoadjuvant 5-fluorouracil/oxaliplatin/docetaxel versus docetaxel/oxaliplatin/S-1 for patients with type 4 or large type 3 gastric cancer
    Hashimoto, Tadayoshi
    Nakayama, Izuma
    Ohashi, Manabu
    Mizusawa, Junki
    Kawachi, Hiroshi
    Kita, Ryosuke
    Fukuda, Haruhiko
    Kurokawa, Yukinori
    Boku, Narikazu
    Yoshikawa, Takaki
    Terashima, Masanori
    FUTURE ONCOLOGY, 2023, : 2147 - 2155
  • [37] Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer
    Ryu, Min-Hee
    Yoo, Changhoon
    Kim, Jong Gwang
    Ryoo, Baek-Yeol
    Park, Young Soo
    Park, Sook Ryun
    Han, Hye-Suk
    Chung, Ik Joo
    Song, Eun-Kee
    Lee, Kyung Hee
    Kang, Seok Yun
    Kang, Yoon-Koo
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (04) : 482 - 488
  • [38] Multicenter phase II study of docetaxel plus oxaliplatin combination chemotherapy in patients with advanced gastric cancer: Daegu Gyeongbuk Oncology Group
    Kim, J. G.
    Sohn, S. K.
    Sohn, Y. S.
    Chae, Y. S.
    Song, H. S.
    Kwon, K. -Y
    Do, Y. R.
    Kim, M. K.
    Lee, K. H.
    Hyun, M. S.
    Ryoo, H. M.
    Bae, S. H.
    Park, K. U.
    Lee, W. S.
    Baek, J. H.
    Chung, H. Y.
    Yu, W.
    BRITISH JOURNAL OF CANCER, 2008, 98 (03) : 542 - 546
  • [39] Multicenter phase II study of docetaxel plus oxaliplatin combination chemotherapy in patients with advanced gastric cancer: Daegu Gyeongbuk Oncology Group
    J G Kim
    S K Sohn
    Y S Chae
    H S Song
    K-Y Kwon
    Y R Do
    M K Kim
    K H Lee
    M S Hyun
    H M Ryoo
    S H Bae
    K U Park
    W S Lee
    J H Baek
    H Y Chung
    W Yu
    British Journal of Cancer, 2008, 98 : 542 - 546
  • [40] Phase II study of the paclitaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL) regimen in the treatment of advanced or metastatic gastric cancer
    Jung, Joo Young
    Kwon, Jung Hye
    Kim, Jung Han
    Song, Hun Ho
    Kim, Inho
    Lee, Keun Seok
    Kim, Hyo Jung
    Zang, Dae Young
    Ahn, Jin Seok
    Lee, Jung-Ae
    Park, Young-Iee
    ONCOLOGY REPORTS, 2009, 21 (02) : 523 - 529
12345